InsiderTrades

Form 4 for HNGE Hinge Health, Inc.

Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001193125-25-290167 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2025-11-20 2025-11-18 HNGE Deer X & Co. L.P. 10% S - Sale $40.05 -725.0K 3.38M -18% -$29.04M
DI 2025-11-20 2025-11-18 HNGE Deer X & Co. L.P. 10% C - Cnv Deriv — +4.11M 4.11M New —
DI 2025-11-20 2025-11-18 HNGE Deer X & Co. L.P. 10% C - Cnv Deriv — -4.11M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-11-18 S D 725,000 $40.05 3,383,707 I See footnote — — (F2) BVP X sold 373,955 shares of Class A Common Stock of the Issuer, and BVP X Inst. sold 351,045 shares of Class A Common Stock of the Issuer. (F3) Deer X & Co. Ltd. is the general partner of Deer X & Co. L.P., which is the general partner of each of Bessemer Venture Partners X L.P. ("Bessemer X") and Bessemer Venture Partners X Institutional L.P. ("Bessemer X International," and together with Bessemer X, the "Bessemer Entities"). As a result, each of Deer X & Co. Ltd. and Deer X & Co. L.P. may be deemed to share beneficial ownership of the securities held by the Bessemer Entities. (F4) Consists of (i) 1,745,316 shares held by BVP X and (ii) 1,638,391 shares held by BVP X Inst.
2 Common Class A Common Stock 2025-11-18 C A 4,108,707 — 4,108,707 I See footnote — — (F1) On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. (F3) Deer X & Co. Ltd. is the general partner of Deer X & Co. L.P., which is the general partner of each of Bessemer Venture Partners X L.P. ("Bessemer X") and Bessemer Venture Partners X Institutional L.P. ("Bessemer X International," and together with Bessemer X, the "Bessemer Entities"). As a result, each of Deer X & Co. Ltd. and Deer X & Co. L.P. may be deemed to share beneficial ownership of the securities held by the Bessemer Entities.
3 Derivative Class B Common Stock 2025-11-18 C D 4,108,707 — 0 I See footnote — · — to — 4,108,707 Class A Common Stock (F1) On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. (F3) Deer X & Co. Ltd. is the general partner of Deer X & Co. L.P., which is the general partner of each of Bessemer Venture Partners X L.P. ("Bessemer X") and Bessemer Venture Partners X Institutional L.P. ("Bessemer X International," and together with Bessemer X, the "Bessemer Entities"). As a result, each of Deer X & Co. Ltd. and Deer X & Co. L.P. may be deemed to share beneficial ownership of the securities held by the Bessemer Entities.